Enalapril Teva-Ratiopharm 20 mg tablets EFG
Spain
Table of Contents
- Patient Information Leaflet
- Introduction
- 1. What Enalapril Teva-ratiopharm is and what it is used for
- 2. What you need to know before taking Enalapril Teva-ratiopharm
- 3. How to take Enalapril Teva-ratiopharm
- 4. Possible adverse effects
- 5. Conservation of Enalapril Teva-ratiopharm
- 6. Contents of the pack and other information
Patient Information Leaflet
Introduction
Patient Information Leaflet
Enalapril Teva-ratiopharm 20 mg tablets EFG
enalapril maleate
Read the entire leaflet carefully before you start taking this medicine, as it contains important information for you.
|
Package leaflet contents
- What Enalapril Teva-ratiopharm is and what it is used for.
- What you need to know before taking Enalapril Teva-ratiopharm
- How to take Enalapril Teva-ratiopharm
- Possible side effects
- How to store Enalapril Teva-ratiopharm
- Contents of the pack and other information
1. What Enalapril Teva-ratiopharm is and what it is used for
Enalapril Teva-ratiopharm belongs to a group of medicines called angiotensin-converting enzyme inhibitors (ACE inhibitors).
Enalapril Teva-ratiopharm is indicated for:
- Treating hypertension (high blood pressure).
- Treating symptomatic heart failure.
- Preventing symptomatic heart failure.
This medicine works by widening your blood vessels, thereby lowering your blood pressure. The medicine usually starts to work within one hour, and the effect lasts for at least 24 hours. Some people may need several weeks of treatment before the full effect on blood pressure is seen.
2. What you need to know before taking Enalapril Teva-ratiopharm
Do not take Enalapril Teva-ratiopharm
- If you are allergic to enalapril maleate or any of the other ingredients of this medicine (listed in section 6).
- If you have ever been treated for an allergic reaction to a medicine similar to this one, called an ACE inhibitor.
- If you have ever had swelling of the face, lips, mouth, tongue or throat causing difficulty swallowing or breathing (angioedema) when the cause was hereditary or unknown.
- If you have diabetes or kidney failure and are being treated with a blood pressure-lowering medicine containing aliskiren.
- If you are more than 3 months pregnant. (It is also advisable to avoid Enalapril Teva-ratiopharm in early pregnancy – see Pregnancy section).
- If you have taken or are currently taking sacubitril/valsartan, a medicine used to treat a type of long-term (chronic) heart failure in adults, as the risk of angioedema (rapid swelling under the skin, for example in the throat) is high.
Do not take this medicine if any of the above situations apply to you. If you are unsure, consult your doctor or pharmacist before starting to take this medicine.
Warnings and precautions
Talk to your doctor or pharmacist before starting to take Enalapril Teva-ratiopharm
- If you have heart disease.
- If you have a disease affecting the blood vessels in the brain.
- If you have blood disorders such as low or absent white blood cells (neutropenia/agranulocytosis), low platelet count (thrombocytopenia), or low red blood cell count (anemia).
- If you have liver problems.
- If you have kidney problems (including kidney transplant), are on a salt-free diet, are taking potassium supplements, potassium-sparing medicines, salt substitutes containing potassium, or other medicines that may increase potassium levels in the blood, such as heparin (a medicine used to prevent blood clots), trimethoprim-containing medicines or cotrimoxazole, also known as trimethoprim/sulfamethoxazole (medicines used to treat infections). This may lead to high potassium levels in the blood, which can be serious. Your doctor may need to adjust your enalapril dose or monitor your blood potassium levels. See also information under the heading “Taking Enalapril Teva-ratiopharm with other medicines”.
- If you are undergoing dialysis.
- If you have had repeated vomiting (excessive vomiting) or severe diarrhoea recently.
- If you have diabetes. You should closely monitor your blood glucose levels, especially during the first month of treatment. Your blood potassium level may also be higher.
- If you have ever had an allergic reaction with swelling of the face, lips, tongue or throat causing difficulty swallowing or breathing. Please note that black patients are more sensitive to this type of reaction to ACE inhibitors.
- If you have low blood pressure (you may experience fainting or dizziness, especially with initial doses and when standing up).
- If you have a vascular collagen disease (e.g. systemic lupus erythematosus, rheumatoid arthritis or scleroderma), are being treated with medicines that suppress your immune system, or are taking allopurinol or procainamide, or any combination of these.
- If you are taking any of the following medicines, your risk of developing angioedema may increase:
- racecadotril, a medicine used to treat diarrhoea.
- medicines used to prevent rejection of organ transplants and for cancer (e.g. sirolimus, everolimus, temsirolimus).
- vildagliptin, a medicine used to treat diabetes.
- If you are taking any of the following medicines used to treat high blood pressure:
- an angiotensin II receptor antagonist (ARA) (also known as “sartans” – for example, valsartan, telmisartan, irbesartan), particularly if you have kidney problems related to diabetes.
- aliskiren.
Your doctor may monitor your kidney function, blood pressure and blood electrolyte levels (e.g. potassium) at regular intervals.
See also information under the heading “Do not take Enalapril Teva-ratiopharm”.
You should inform your doctor if you think you are pregnant (or might be). This medicine is not recommended in early pregnancy and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at this stage (see Pregnancy section).
Please note that this medicine is less effective in lowering blood pressure in black patients than in non-black patients.
If you are unsure whether any of the above situations apply to you, consult your doctor or pharmacist before starting to take this medicine.
If you are about to undergo a procedure
If you are about to undergo any of the following procedures, inform your doctor that you are taking enalapril:
- any surgery or if you are to receive anaesthetics (including at the dentist's),
- a treatment to remove cholesterol from your blood called “LDL apheresis”,
- a desensitisation treatment to reduce the effect of an allergy to bee or wasp stings.
If any of the above situations apply to you, consult your doctor or dentist before starting the procedure.
Taking Enalapril Teva-ratiopharm with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken or might need to take any other medicines. This includes herbal remedies. This is because enalapril may affect how other medicines work, and certain medicines may also affect how enalapril works. Your doctor may need to adjust your dose and/or take other precautions.
In particular, inform your doctor or pharmacist if you are taking any of the following medicines:
- An angiotensin II receptor antagonist (ARA) or aliskiren (see also information under the headings “Do not take Enalapril Teva-ratiopharm” and “Warnings and precautions”).
- Other medicines to lower blood pressure such as beta-blockers or water tablets (diuretics).
- Potassium supplements (including salt substitutes), potassium-sparing diuretics, and other medicines that may increase potassium levels in the blood (e.g. trimethoprim and cotrimoxazole for bacterial infections; cyclosporine, an immunosuppressant medicine used to prevent rejection of organ transplants; and heparin, a medicine used to thin the blood to prevent clots). See also information in the section “Warnings and precautions”.
- Medicines for diabetes (including oral antidiabetics and insulin).
- Lithium (a medicine used to treat certain types of depression).
- Medicines for depression called “tricyclic antidepressants”.
- Medicines for mental disorders called “antipsychotics”.
- Certain cough and cold medicines and weight-reducing medicines containing a substance called “sympathomimetic medicine”.
- Certain medicines for pain or arthritis, including gold treatment.
- An mTOR inhibitor (e.g. temsirolimus, sirolimus, everolimus; medicines used to treat certain types of cancer or to prevent the immune system rejecting a transplanted organ). See also information in the section “Warnings and precautions”.
- A medicine containing sacubitril/valsartan, racecadotril or vildagliptin. This may increase the risk of angioedema (swelling of the face, lips, tongue or throat with difficulty swallowing or breathing). See also “Do not take Enalapril Teva-ratiopharm” and “Warnings and precautions”.
- Non-steroidal anti-inflammatory drugs (NSAIDs), including COX-2 inhibitors (medicines that reduce inflammation and may help relieve pain).
- Aspirin (acetylsalicylic acid).
- Medicines used to dissolve blood clots (thrombolytics).
- Alcohol.
If you are unsure whether any of the above situations apply to you, consult your doctor or pharmacist before starting to take enalapril.
Taking Enalapril Teva-ratiopharm with food, drinks and alcohol
Enalapril can be taken with or without food. Most people take enalapril with a little water.
Pregnancy, breastfeeding and fertility
If you are pregnant or breastfeeding, think you may be pregnant or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Pregnancy
Inform your doctor if you think you are pregnant (or might be). Your doctor will usually advise you to stop taking enalapril before becoming pregnant or as soon as you know you are pregnant, and will recommend an alternative medicine to Enalapril Teva-ratiopharm. Enalapril Teva-ratiopharm is not recommended in early pregnancy and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used from the third month of pregnancy onwards.
Breastfeeding
Inform your doctor if you are breastfeeding or about to start breastfeeding. Breastfeeding is not recommended while taking enalapril in newborns (first weeks after birth), and especially in premature babies. For an older infant, your doctor should advise you on the benefits and risks of taking enalapril compared with other treatments while breastfeeding.
Driving and using machines
You may feel dizzy or drowsy while taking this medicine. If this occurs, do not drive or operate tools or machinery.
Enalapril Teva-ratiopharm contains lactose and sodium
If your doctor has told you that you have an intolerance to certain sugars, consult with him before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially “sodium-free”.
3. How to take Enalapril Teva-ratiopharm
Follow exactly the instructions for administration of this medicine as given by your doctor. In case of doubt, please consult your doctor or pharmacist again.
Remember to take your medicine.
It is very important that you continue taking this medicine for as long as your doctor has prescribed it.
Do not take more tablets than prescribed.
The recommended dose is:
Hypertension
The usual recommended starting dose is 5 to 20 mg once daily.
Some patients may require a lower initial dose.
The usual long-term dose is 20 mg once daily.
The maximum long-term dose is 40 mg once daily.
Heart failure
The usual recommended starting dose is 2.5 mg once daily.
Your doctor will gradually increase the dose until the appropriate dose for you is reached.
The usual long-term dose is 20 mg daily, given in one or two doses.
The maximum long-term dose is 40 mg once daily, divided into two doses.
Patients with kidney problems
Your dose will depend on how well your kidneys are functioning:
- moderate kidney problems – 5 mg to 10 mg daily
- severe kidney problems – 2.5 mg daily
- if undergoing dialysis – 2.5 mg daily. On days when you are not undergoing dialysis, your dose may be adjusted depending on how low your blood pressure is.
Elderly patients
Your doctor will decide the dose based on kidney function.
Use in children
Experience with enalapril in children with high blood pressure is limited. If the child can swallow tablets, the dose will be calculated based on the child's weight and blood pressure. The usual starting doses are:
- between 20 kg and 50 kg – 2.5 mg daily
- over 50 kg – 5 mg daily.
The dose may be adjusted according to the child's needs:
- a maximum of 20 mg daily may be used in children weighing between 20 kg and 50 kg
- a maximum of 40 mg daily may be used in children weighing over 50 kg.
This medicine is not recommended in newborn infants (first weeks after birth) or in pediatric patients with kidney problems.
If you take more Enalapril Teva-ratiopharm than you should
If you take more enalapril than you should, contact your doctor or pharmacist immediately.
Take the medicine packaging with you.
In case of overdose, the most likely symptom is dizziness or vertigo due to a sudden or excessive drop in blood pressure.
In case of overdose or accidental ingestion, contact the Toxicology Information Service. Telephone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Enalapril Teva-ratiopharm
Continue taking this medicine as prescribed. Do not take a double dose to make up for forgotten doses.
If you stop taking Teva-ratiopharm
Do not stop taking your medicine unless your doctor tells you to.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
4. Possible adverse effects
Like all medicines, this medicine may cause adverse effects, although not everyone experiences them.
If you experience any of the following symptoms, stop taking this medicine and consult your doctor immediately:
- swelling of the face, lips, tongue, or throat that may cause difficulty breathing or swallowing,
- swelling of the hands, feet, or ankles,
- if you develop a red rash on the skin with swelling (wheals).
Please be aware that patients of black race have a higher risk of experiencing these types of reactions. If you experience any of the above reactions, stop taking the medicine and speak to your doctor immediately.
When you start taking this medicine, you may feel faint or dizzy. If this occurs, lying down may help. This is due to a decrease in your blood pressure. This will improve as you continue taking the medicine. If you are concerned, please speak to your doctor.
Other adverse effects include:
Very common (may affect more than 1 in 10 people):
- dizziness, weakness, or vomiting
- cough
- blurred vision
Common (may affect up to 1 in 10 people):
- dizziness due to low blood pressure, chest pain, changes in heart rhythm, angina, rapid heartbeat
- headache, depression
- difficulty breathing
- tiredness (fatigue)
- diarrhea, abdominal pain
- rash, allergic reactions with swelling of the face, lips, tongue, or throat causing difficulty swallowing or breathing
- elevated levels of potassium in blood, elevated levels of creatinine in blood (both usually detected in a blood test).
Uncommon (may affect up to 1 in 100 people):
-
flushing
-
sudden drop in blood pressure
-
rapid and irregular heartbeat (palpitations)
-
myocardial infarction or stroke possibly due to excessively low blood pressure in high-risk patients (patients with impaired blood flow to the heart and/or brain)
-
anemia (including aplastic and hemolytic anemia)
-
confusion, drowsiness, or inability to sleep, restlessness
-
itching or numbness sensation in the skin
-
vertigo (sensation of dizziness)
-
ringing in the ears (tinnitus)
-
runny nose, sore throat, or hoarseness
-
asthma associated with chest tightness
-
slow movement of food through the intestine (ileus), pancreatitis, vomiting, indigestion, constipation, anorexia
-
irritated stomach (gastric irritation), dry mouth, ulcer
-
muscle cramps
-
reduced kidney function or kidney failure
-
increased sweating
-
itching or hives
-
hair loss
-
malaise (general discomfort), elevated temperature (fever)
-
impotence
-
elevated levels of protein in urine (detected in a test)
-
low blood sugar or sodium levels, elevated blood urea levels (all determined by blood tests).
Rare (may affect up to 1 in 1,000 people):
-
“Raynaud’s phenomenon” in which your hands and feet may become very cold and turn white due to reduced blood flow
-
changes in blood values, such as lower numbers of white or red blood cells, reduced hemoglobin, lower platelet count
-
bone marrow suppression
-
swollen glands in the neck, armpits, or groin
-
autoimmune disorders
-
sleep disturbances or sleep problems
-
fluid or other substances accumulating in the lungs (as seen on X-rays)
-
inflammation of the nose
-
lung inflammation causing difficulty breathing (pneumonitis)
-
inflammation of the cheeks, gums, tongue, lips, throat
-
reduced amount of urine produced
-
target-shaped rash (erythema multiforme)
-
“Stevens-Johnson syndrome” and “toxic epidermal necrolysis” (a serious skin disorder in which you have red, peeling skin, blisters or open sores), exfoliative dermatitis/erythroderma (severe skin rash with peeling or shedding of the skin), pemphigus (small fluid-filled blisters on the skin)
-
liver or gallbladder problems such as reduced liver function, liver inflammation, jaundice (yellowing of the skin or eyes), elevated liver enzymes or bilirubin levels (detected in a blood test)
-
breast enlargement in men (gynecomastia).
Very rare (may affect up to 1 in 10,000 people):
- Intestinal angioedema (swelling in the intestine)
Frequency not known (frequency cannot be estimated from available data):
- excessive production of antidiuretic hormone, causing fluid retention, leading to weakness, fatigue, or confusion
- a symptomatic complex has been reported which may include all or some of the following symptoms: fever, inflammation of blood vessels (serositis, vasculitis), muscle pain (myalgia, myositis), joint pain (arthralgia/arthritis). Skin rash, photosensitivity, or other skin manifestations may occur.
Reporting of adverse effects:
If you experience any adverse effect, talk to your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. You can also report them directly via the Spanish Pharmacovigilance System for Human Medicines: https://www.notificaram.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.
5. Conservation of Enalapril Teva-ratiopharm
Keep this medicine out of the sight and reach of children.
Do not store above 30°C. Store in the original packaging.
Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date refers to the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Dispose of empty containers and unused medicines at the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of containers and unused medicines. This will help protect the environment.
6. Contents of the pack and other information
Composition of Enalapril Teva-ratiopharm 20 mg tablets
The active substance in this medicine is enalapril maleate 20 mg. Each tablet contains 20 mg of enalapril maleate as the active ingredient.
The other components are croscarmellose sodium, monohydrate lactose, magnesium stearate, pregelatinized starch (from corn), sodium bicarbonate, iron oxide red (E-172), iron oxide yellow (E-172), and corn starch.
Appearance of the product and contents of the pack:
Enalapril Teva-ratiopharm 20 mg are light orange, circular, flat, scored tablets. They are supplied in packs of 28 tablets.
Marketing Authorization Holder and Manufacturer:
Marketing Authorization Holder:
Teva Pharma, S.L.U.
C/ Anabel Segura 11, Edificio Albatros B, 1st floor
Alcobendas, 28108 Madrid (Spain).
Manufacturer:
Teva Pharma, S.L.U.
Polígono Malpica c/C nº4
Zaragoza, Spain.
Date of the most recent revision of this leaflet: February 2022
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
You can access detailed and updated information about this medicine by scanning with your mobile phone (smartphone) the QR code included in the packaging. You may also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/66076/P_66076.html